Abstracts from the 2004 Conference, London

View these abstracts sorted by presenting author

1. A METHOD FOR INTERNATIONAL TRANSLATION OF PREVENTABLE DRUG-RELATED MORBIDITY INDICATORS IN COMMUNITY PHARMACY
   Guerreiro M, Cantrill J, Martins P
2. A MULTI-FACULTY STUDY OF ACADEMIC DISHONESTY
   Obiols L., Bates IP, Lacey MF, Austin Z, Davies JG
3. A QUALITATIVE STUDY OF CARDIAC REHABILITATION PATIENTS' PERSPECTIVES ON COMPLIANCE AND CONCORDANCE WITH MEDICINES
   White S, Anderson C, Bissell P.
4. AN EXPLORATION OF THE INFLUENCE OF COMPANY POLICY ON ETHICAL DECISION MAKING BY COMMUNITY PHARMACISTS
   Wingfield J, Theophilou T, Bissell P.
5. 'ASK ABOUT MEDICINES': AN ONLINE QUIZ FOR ADOLESCENTS
   Gray NJ, McPherson A, MacFarlane A
6. BARRIERS TO COMMUNITY NURSE PRESCRIBING
   Hall J, Cantrill J, Noyce P
7. CAN HUMAN ERROR THEORY PREDICT NON-COMPLIANCE? A TEST OF THE MODEL
   Furlong J, Knapp P, Lawton R.
8. CREATING RESEARCH CAPACITY IN COMMUNITY PHARMACY; DILEMMAS IN PRACTICE
   Kirkbride R, Anderson C, Gray N, Thornley T.
9. DIFFERING DEFINITIONS OF APPROPRIATENESS
   Morecroft C, Cantrill J, Tully MP
10. DIVERGENT PERSPECTIVES ON WHO IS RESPONSIBLE FOR PREVENTING DRUG RELATED MORBIDITY
    Howard R, Bissell P, Avery A.
11. DO TOMORROW'S DOCTORS AND PHARMACISTS WANT SHARED LEARNING? ANALYSIS OF A PILOT INTERDISCIPLINARY PROJECT
    Diack HL, Bond CM, Edwards R, Healey TM, Mackenzie H
12. DOSING ERRORS IN PAEDIATRIC MEDICATIONS – A SYSTEMATIC REVIEW
    Ghaleb MA, Wong ICK, Franklin BD, Barber N
13. DRUG-RELATED PROBLEMS: WHAT DO PATIENTS AND HEALTH CARE PROFESSIONALS CONSIDER IMPORTANT?
    Gordon KJ , Dhillon S and Smith FJ
14. EVALUATING PHARMACEUTICAL CONSULTATIONS: THE DEVELOPMENT OF A "MEDICATION-RELATED CONSULTATION FRAMEWORK"
    Abdel Tawab R, James D, Davies JG, & Horne R
15. EXPLORING PSYCHOSOCIAL INFLUENCES ON ADHERENCE TO ANTI-HYPERTENSIVE MEDICATION
    Maguire, L, Hughes, C & McElnay, J.
16. EXPLORING THE EFFECT OF THE ELECTRONIC PATIENT RECORD ON HOSPITAL PHARMACIES: DEVELOPING A CASE STUDY APPROACH
    Smith GM, Cantrill J, Tully MP.
17. FLEXIBILITY & THE LOCUM PHARMACIST
    Shann P, Hassell K, Samuels T.
18. HEALTH CARE OUTCOME INDICATORS ARE RELATED TO HOSPITAL PHARMACY WORKFORCE
    Borja-Lopetegi A, Bates I, Webb DG, Sharott P
19. HOMALS METHOD GUIDING ANALYSIS OF PATIENT CHOICE IN TB PREVENTION
    Rennie TW, Bates IP, Engova D, Bothamley GH
20. HOW CAN COMMUNITY PHARMACISTS ASSESS COMPETENCE?
    Mills ER, Bates I, Davies JG
21. HUMAN ERROR THEORY (HET): A NOVEL APPROACH TO DEVELOPING STRATEGIES TO IMPROVE THE EVIDENCE BASED(EB) SUPPLY OF NON-PRESCRIPTION MEDICINES(NPMS)
    Watson MC, Bond CM, Johnston M, Mearns K.
22. IDENTIFYING OPPORTUNITIES FOR PHARMACY INVOLVEMENT IN ASTHMA SERVICES: RESULTS FROM AN OMNIBUS SURVEY
    Thornley T, Anderson C, Gray N, Kirkbride R.
23. INDICATORS FOR PREVENTABLE DRUG-RELATED MORBIDITY: FACILITATING CHANGES IN PRACTICE?
    Morris CJ, Cantrill JA, Avery AJ, Howard RL
24. INNOVATION IN COMMUNITY PHARMACY CONTRACTS: DESCRIBING FIRST WAVE LOCAL PHARMACEUTICAL SERVICES (LPS) PILOTS.
    Kendall J, Sibbald B, Ashcroft D, Hassell K & Noyce P.
25. LESSONS FROM ABROAD: THE ROLES AND RESPONSIBILITIES OF PHARMACY ASSISTANTS
    Samuels T, Mullen R, Hassell K, Noyce P.
26. MOVEMENT OF GB TRAINED PHARMACISTS OVERSEAS
    Liza Nichols, Karen Hassell, Peter Noyce
27. PATIENTS' EXPERIENCES OF EDUCATING PHARMACY UNDERGRADUATES
    Shah, R., Kapadia, S., Savage, I.
28. PREDICTING PRESCRIBING TRENDS IN GENERAL PRACTICE
    Åström K, Duggan C, Bates I
29. RELATIONSHIP BETWEEN THE RATE OF PARACETAMOL OVERDOSE AND DEPRIVATION
    Robinson D, Johnston D, McElnay J.
30. REMOTE SUPERVISION: THE VIEWS OF PHARMACY CUSTOMERS
    Bissell P & Anderson C.
31. RESEARCH CAPACITY BUILDING: VIEWS OF COMMUNITY PHARMACISTS PARTICIPATING IN A COMMUNITY PHARMACIES NETWORK
    Schafheutle EI, Hassell K, Noyce PR
32. RESEARCH EVIDENCE AND ITS INFLUENCE ON POLICY: PROGRESS IN DELIVERING IMPROVED SERVICES TO DRUG USERS
    Keith Wilson Jill Jesson and Christabel Tattersall
33. SELF-MANAGEMENT, WELL-BEING AND LEARNING
    Silcock J, Raynor DK, Atkin K.
34. SKILL MIX IN COMMUNITY PHARMACY: A CASE STUDY APPROACH TO EXPLORE THE ACTIVITIES OF DISPENSARY SUPPORT STAFF
    Mullen R. Hassell and Noyce PR
35. SOCIAL CAPITAL AND PHARMACY: AN EXPLORATORY STUDY
    Fenner L, Bissell P, Anderson C.
36. STATINS AND THE INTERFACE BETWEEN PATIENT AND COMMUNITY PHARMACIST
    Chatterton M, Blenkinsopp A, Pollock K.
37. SYSTEMATIC REVIEW OF THE ANALGESIC EFFICACY AND TOLERABILITY OF COX-2 INHIBITORS IN POSTOPERATIVE PAIN CONTROL
    Chen L, Elliott R, Ashcroft D
38. "THE CHANCE TO DEVELOP MYSELF": THE ASPIRATIONS OF ESSEX PHARMACY TECHNICIANS
    Savage I, Duell P, Stanley J, Nice S, Allan J, Smith P
39. THE DEVELOPMENT OF THE SOUTHERN DERBYSHIRE MEDICINES SUPPORT SERVICE
    Harris DJ
40. THE MEDICINES INFORMATION NEEDS OF OLDER PEOPLE WITH SIGHT LOSS: PRELIMINARY FINDINGS
    Gibson M, Knapp P, Turpin P, Raynor DK, Atkin K
41. THE USE OF PERMITTED AND BANNED MEDICINES IN RUGBY UNION BY MEN – A QUESTIONNAIRE STUDY
    John DN, Phillips H
42. UNDERSTANDING ADHERENCE TO ANTIBIOTICS: A PROSPECTIVE STUDY
    Knapp P., Jackson, C., Raynor, D.K., Lawton, R. & Lowe, C.
43. USING EMAIL AND THE INTERNET AS A DATA COLLECTION TOOL IN PHARMACY PRACTICE RESEARCH
    Liza Nichols, Karen Hassell, Peter Noyce
44. WHAT DO PEOPLE THINK IS THE LIKELIHOOD OF HARM AND BENEFIT FROM TWO COMMON MEDICINES?
    Peter Knapp, Zubeena Coppack and DK Theo Raynor
45. WHAT IS DRIVING LOCAL DEVELOPMENT OF COMMUNITY PHARMACY?
    Celino GJ, Gray NJ, Blenkinsopp A, Dhalla M
46. WHAT IS THE EVIDENCE FOR THE USE OF MULT-COMPARTMENT COMPLIANCE AIDS BY OLDER PEOPLE LIVING IN THE COMMUNITY?
    Nunney J, Raynor DK, Knapp PR.